According to the company, dark adaptation measures the eye’s ability to adapt to light and dark environments. Poor dark adaptation can be one of the first indicators of AMD, which is the leading cause of vision loss and accounts for 8.7% of visual impairment worldwide.1 Early detection of AMD is key to preserve visual function and research indicates that 78% of patients do not seek treatment until it is too late.
In a press release, the company noted that its AMD portfolio takes advantage of contrast sensitivity and dark adaptation, which studies show can help doctors detect AMD-related changes. up to three years before drusen are visible, allowing earlier intervention and management of the disease.
Mohamed Abou Shousha, MD, PhD, CEO and Founder of Heru, noted in the press release that the release of the dark adaptation further advances the company’s platform and fulfills its commitment to establishing a comprehensive portfolio of ‘AMD laptops.
“With this release, Heru can confidently say that we are leading the way in vision and now AMD, transforming the way clinicians are able to assess retinal function,” he said in a statement. . “With the introduction of each new eye exam, Heru’s proprietary technology continues to better serve patients by aiding in the detection of multiple sight-threatening conditions while creating unique revenue streams to support practice growth. .”
Age-related macular degeneration is four times more common than glaucoma2, affecting 1 in 8 adults over the age of 60.3 For patients over 50, performing visual field, contrast sensitivity and dark adaptation should be an integral part of their annual comprehensive eye exam. .
“Multi-functional devices like Heru’s are the future of vision care,” said Barry Eiden, OD, FAAO, founder of North Suburban Vision Consultants, in the release.
Eiden noted that dark adaptation testing with the Heru platform was something he was looking forward to adopting in his practice.
“With Heru, we are better equipped to detect dark adaptation disorders, which studies have shown to be an early indicator of AMD,” he said in the statement. “Having the test complement a device already in our practice is a major point of value, and we’re excited about the additional capabilities to improve patient care and move the industry forward.”
Compared to existing devices, Heru’s dark adaptation exam is simple, non-invasive and takes only 4.5 minutes for a quick exam or 20 minutes for an extended exam. Dark adaptation is billable to insurance with a national reimbursement average of $58.83 and is co-billable with visual fields, OCT, fundus imaging and/or office visits. The dark adaptation has multiple supported ICD-10 codes and can generate additional practice revenue through ancillary testing, as well as nutraceutical and optical sales.
“Dark adaptation may allow physicians to more effectively monitor the progression of AMD at regular intervals and identify rapid progressors. More frequent visits and proactive treatment should become the standard of care and could result in a improved clinical outcomes and patient compliance,” added Gregory Caldwell, OD, FAAO, Co-Founder, Johnstown Family Vision. “Heru’s extensive suite of available testing modalities has filled a major gap in screening for the vision. I can’t wait to see what the company does next.
To learn more about the Heru platform and available testing modalities, visit seeheru.com.